
| Welcome Address Vincent Castonguay |
VIEW |
| Keynote Lecture Refining Systemic Therapy for Localized Bladder Cancer Elizabeth Plimack |
VIEW |
| Liquid Biopsy and Response to Chemotherapy in Metastatic Prostate Cancer Kim Chi |
VIEW |
| Evolution of Systemic Therapy For Metastatic Bladder Cancer: Where We Are Now and What’s on The Horizon Elizabeth Plimack |
VIEW |
| Advanced Clear Cell Renal Cell Carcinoma: State of the Art and Future Options Christian Kollmannsberger |
VIEW |
| PSMA PET/CT and Therapy for Prostate Cancer Stephan Probst |
VIEW |
| ASCO Prostate Cancer Update Shaan Dudani |
VIEW |
| Best of ASCO: Urothelial Cancer Di (Maria) Jiang |
VIEW |
| Updates in Systemic Therapy in Renal Cell Carcinoma Maryam Soleimani |
VIEW |
| Inequities of Access to Advanced Prostate Cancer Igal Kushnir |
VIEW |
| Molecular and Profiling and Outcomes of Metastatic Castrate Sensitive Prostate Cancer: A Prospective Cohort Study Di (Maria) Jiang |
VIEW |
| Deep Immune Profiling of Patients with Metastatic Urothelial or Renal Cell Cancer Receiving Immune Checkpoint Inhibitors Jean-Michel Lavoie |
VIEW |
| Update on CCTG Trials : Prostate Kim Chi |
VIEW |
| Update on CCTG Trials : Bladder Kala Sridhar |
VIEW |
| Update on CCTG Trials: Kidney Daniel Heng |
VIEW |
| Cases Moderator: Dominick Bossé |
VIEW |
| Closing Remarks and Adjournment Dean Ruether |
VIEW |